<?xml version="1.0" encoding="UTF-8"?>
<p id="Par12">The engraftment endpoint was based on neutrophil engraftment with absolute neutrophil count (ANC) ≥ 0.5×10
 <sup>9</sup>/l for 3 consecutive days after transplantation without G-CSF. Platelet engraftment was defined as the first of 7 consecutive days with platelet counts of &gt;20×10
 <sup>9</sup>/l without platelet transfusion. Graft failure was defined as failure of neutrophil engraftment on day 28 following transplantation (primary graft failure), or loss of donor chimerism after initial engraftment with ≥95% recipient cells at any time, not due to relapsed disease (secondary graft failure) [
 <xref ref-type="bibr" rid="CR14">14</xref>].
</p>
